Clinical applications of therapeutic apheresis.
نویسندگان
چکیده
Rasheed A. Balogun,* Andre Kaplan, David M. Ward, Chidi Okafor, Ted M. Burns, A. Sergio Torloni, B. Gail Macik, and Emaad M. Abdel-Rahman Department of Medicine, Division of Nephrology, University of Virginia Health System, Charlottesville, Virginia Department of Medicine, University of Connecticut Health Center, Farmington, Connecticut Department of Medicine, University of California, San Diego, California Department of Neurology, University of Virginia, Charlottesville, Virginia Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona Division of Hematology, Department of Medicine, University of Virginia, Charlottesville, Virginia
منابع مشابه
The new approach to assignment of ASFA categories--introduction to the fourth special issue: clinical applications of therapeutic apheresis.
The American Society for Apheresis (ASFA) Apheresis Applications Committee is responsible for a review and categorization of indications for therapeutic apheresis. The results of the review process were previously published in 1986, 1993, and 2000 as the ASFA Special Issues. The ASFA categories consist of categories I through IV, and category P (pending). This article describes the novel method...
متن کاملGuidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.
The American Society for Apheresis (ASFA) Apheresis Applications Committee is charged with a review and categorization of indications for therapeutic apheresis. Beginning with the 2007 ASFA Special Issue (fourth edition), the subcommittee has incorporated systematic review and evidence-based approach in the grading and categorization of indications. This Fifth ASFA Special Issue has further imp...
متن کاملTherapeutic cytapheresis: too many platelets, too many white blood cells.
Myeloproliferative disorders may present with thrombocytosis and/or leukocytosis with symptoms ranging from minor to life-threatening. Therapeutic cytapheresis (TC), the removal of excess and/or abnormal cells such as platelets and white blood cells, can be used to rapidly reduce cells in the symptomatic patient. The patient's clinical status determines the need for TC as symptoms may not corre...
متن کاملGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating, and categorizing indications for the evidence-based use of therapeutic apheresis in human disease. Since the 2007 JCA Special Issue (Fourth Edition), the Committee has incorporated systematic review and evidence-based approaches in the grading and ca...
متن کاملThe Italian Registry for Therapeutic Apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology.
Many clinical indications and different technical issues have been reported on therapeutic apheresis: much criticism has also been recorded in several instances, mainly due to the lack of large clinical trials to validate collected data. A Registry where all the available data can be organized and analyzed therefore becomes a priority for all the professionals involved in apheresis. The purpose...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of clinical apheresis
دوره 25 5 شماره
صفحات -
تاریخ انتشار 2010